Home | Services | Products | Support | Useful Documents | Experience | Staff | Opportunities  
 
         
 

is an economic consulting company that utilises leading
edge tools and approaches to assist investors,
researches and policy makers in a range of bio-science fields

Learn more about

 

 

Ross McLeod joins the Royal Australasian College of Surgeons for Swiss Federal Office of Public Health study of calcitonin gene-related peptide antagonists for the prevention of migraine.

  FOPH note the aim of the HTA is to evaluate the effectiveness, safety, costs, cost-effectiveness and budget impact of CGRP antagonists compared to standard of care medications in patients who suffer from episodic and/or chronic migraine.
 

News
  eSYS Development
  contracted with the...
  Ross McLeod joins the
  Royal Australasian...
  Ross McLeod joins the
  Royal Australasian...
More
Ross McLeod joins the Royal Australasian College of Surgeons for Swiss Federal Office of Public Health study of long-term physiotherapy in patients after stroke, with multiple sclerosis, or with Parkinsonís disease.
Ross McLeod joins World Health Organization Technical and Scientific Advisory Group on the Development of Target Product Profiles (TPPs) for Snake Antivenom Products.
Annual Costs of Feral Deer in Australia.
Ross McLeod Joins the UNITAID Proposal Review Committee.
 
Services
  The collection and
  analysis of market...
  eSYS Development
  environmental...
  The World Health
  Report (WHR) 1999...
More
Health
Environment
Agriculture
R&D Advice
Infomation Technology
Market Assessment
 
Experience
Africa
Australia
South Asia
South East Asia
Europe
Other Regions
Health
Environment
Agriculture